Aisling Capital V, LP 13D and 13G filings for Spruce Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-06 4:15 pm Purchase |
2023-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Aisling Capital V, LP | 1,205,511 3.000% |
1,205,511 (New Position) |
Filing |